Literature DB >> 30712801

Limitations of simulation models for cervical cancer screening.

Anne Hammer1, Rebecca Landy2, Anne F Rositch3, Patti E Gravitt4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30712801      PMCID： PMC6817970          DOI： 10.1016/S1470-2045(19)30011-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.

Authors:  Talía Malagón; Shalini Kulasingam; Marie-Hélène Mayrand; Gina Ogilvie; Leah Smith; Céline Bouchard; Walter Gotlieb; Eduardo L Franco
Journal:  Lancet Oncol       Date:  2018-11-01       Impact factor: 41.316

2.  How confident can we be in the current guidelines for exiting cervical screening?

Authors:  Patti E Gravitt; Rebecca Landy; Mark Schiffman
Journal:  Prev Med       Date:  2018-07-05       Impact factor: 4.018

3.  Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.

Authors:  Marc D Ryser; Anne Rositch; Patti E Gravitt
Journal:  J Infect Dis       Date:  2017-09-01       Impact factor: 5.226

4.  Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.

Authors:  Anne F Rositch; Rebecca G Nowak; Patti E Gravitt
Journal:  Cancer       Date:  2014-05-12       Impact factor: 6.860

5.  Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.

Authors:  Shalini L Kulasingam; Laura J Havrilesky; Rahel Ghebre; Evan R Myers
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.